Hirsutism in women: Effective therapy that is safe for long-term use

Postgraduate Medicine

Volumn 107, Issue 7, 2000, Pages 93-104

  Bergfeld, Wilma F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANABOLIC AGENT; ANDROGEN; ANTIANDROGEN; CIMETIDINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOSPORIN A; CYPROTERONE ACETATE; DANAZOL; DEXAMETHASONE; DIAZOXIDE; ETHINYLESTRADIOL; FINASTERIDE; FLUTAMIDE; GESTAGEN; GLUCOCORTICOID; GONADORELIN AGONIST; HEXACHLOROBENZENE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; KETOCONAZOLE; METYRAPONE; MINOXIDIL; ORAL CONTRACEPTIVE AGENT; PENICILLAMINE; PHENOTHIAZINE DERIVATIVE; PHENYTOIN; PRASTERONE SULFATE; PREDNISONE; PSORALEN DERIVATIVE; SPIRONOLACTONE; STEROID 21 MONOOXYGENASE; TESTOSTERONE;

ADRENAL DISEASE; BIRTH CONTROL; CLINICAL FEATURE; CONFERENCE PAPER; DRUG INDUCED DISEASE; FEMALE; HIRSUTISM; HORMONE SUBSTITUTION; HYPERANDROGENISM; LABORATORY TEST; OVARY POLYCYSTIC DISEASE; STEROID 21 MONOOXYGENASE DEFICIENCY; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0033916744     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2000.06.1112     Document Type: Conference Paper

References (40)

1. Redmond GP, Bergfeld WF. Diagnostic approach to androgen disorders in women: acne, hirsutism, and alopecia. Cleve Clin J Med 1990;57(5):423-7
2. Bergfeld WF. Androgens and women's health: androgenic alopecia. Clinician 1994;12(3):10-11
3. McKnight E. The prevalence of "hirsutism" in young women. Lancet 1964;41(Feb 22):410-3
4. Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol 1998;139(4):421-3
5. Escobar-Morreale HF, Serrano-Gotarredona J, Garcia-Robles R, et al. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metabolism 1997;46(8):902-7
6. Martins JM, Carreiras F, Afonso A, et al. Transient hyperandrogenemia and its relation to ovulation. Fertil Steril 1998;70(4): 664-70
7. Bals-Pratsch M, Hanker JP, Hellhammer DH, et al. Intermittent Cushing's disease in hirsute women. Horm Metab Res 1996; 28(2):105-10
8. Carmina E, Gentzschein E, Stanczyk FZ, et al. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen. Hum Reprod 1995;10(2): 229-303
9. Loughlin T, Cunningham S, Moore A, et al. Adrenal abnormalities in polycystic ovary syndrome. J Clin Endocrinol Metab 1986; 62(1):142-7
10. Knochenhauer ES, Azziz R. Advances in the diagnosis and treatment: of the hirsute patient. Curr Opin Obstet Gynecol 1995; 7(5):344-50
11. Azziz R, Rittmaster RS, Fox LM, et al. Role of the ovary in the adrenal androgen excess of hyperandrogenic women. (Comment) Fertil Steril 1998;70(6):1187-9
12. Rieu M, Mourrieras F, Riveline JP, et al. High serum luteinizing hormone levels induce ovarian delta4 cytochrome P450cl7alpha down-regulation in hirsute women: complete effect on 17-hydroxylase and partial effect on 17,20-lyase. Eur J Endocrinol 1998;139(3): 304-8
13. Lucky AW. Hormonal correlates of acne and hirsutism. Am J Med 1995;98(1A):89-94S
14. Rosenfield RL. Current concepts of polycystic ovary syndrome. Baillieres Clin Obstet Gynecol 1997;11(2):307-33
15. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450cl7 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335(9):617-23
16. Ehrmann DA. Insulin-lowering therapeutic modalities for polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28(2):423-38
17. Paoletti AM, Cagnacci A, Orru M, et al. Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. Fertil Steril 1999;72(3):448-53
18. De Leo V, la Marca A, Ditto A, et al. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999;72(2):282-5
19. Ayuk P, Stringfellow H, Donnai P, et al. Hirsutism of recent onset with marked hyperandrogenaemia and ovarian hyperthecosis after the menopause. Ann Clin Biochem 1998;35(Pt 1):145-8
20. Barth JH, Jenkins M, Belchetz PE. Ovarian hyperthecosis, diabetes and hirsutism in post-menopausal women. (Comment) Clin Endocrinol (Oxf) 1997;46(2):129-30
21. Keslestimur F, Sahin Y, Ayata D, et al. The prevalence of non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency among hirsute women in a Turkish population. Clin Endocrinol (Oxf) 1996;45(4):381-4
22. Venturoli S, Ravaioli B, Bagnoli A, et al. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients. Eur J Contracept Reprod Health Care 1998;3(1):29-33
23. Falsetti L, Rosina B, De Fusco D. Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women. Eur J Endocrinol 1998;138(4):421-4
24. Young R, Sinclair R. Hirsutes. Part II: treatment. Australas J Dermatol 1998;39(3):151-7
25. Redmond GP, Bergfeld WF. Treatment of androgenic disorders in women: acne, hirsutism, and alopecia. Cleve Clin J Med 1990;57(5):428-32
26. Barth JH. Investigations in the assessment and management of patients with hirsutism. Curr Opin Obstet Gynecol 1997;9(3):187-92
27. Fruzzetti F, Bersi C, Parrini D, et al. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects. Fertil Steril 1999;7(3):445-51
28. Carmina E, Lobo RA. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission. Fertil Steril 1998;69(6):1075-9
29. Muderris II, Bayram F. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism. J Endocrinol Invest 1999; 22(3):165-8
30. Wheeland RG. Laser-assisted hair removal. Dermatol Clin 1997;15(3):469-77
31. Crave JC, Fimbel S, Lejeune H, et al. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995;80(7):2057-62
32. Elkind-Hirsch KE, Anania C, Mack M, et al. Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism. Fertil Steril 1995;63(5):970-8
33. Erenus M, Yucelten D, Durmusoglu F, et al. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism. Fertil Steril 1997;68(6):1000-3
34. Bertoli A, Fusco A, Magnani A, et al. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism. Exp Clin Endocrinol Diabetes 1995;103(1):15-20
35. Erenus M, Yucelten D, Gurbuz O, et al. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Fertil Steril 1996;66(2):216-9
36. Rittmaster RS. Antiandrogen treatment of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28(2):409-21
37. Kelestimur F, Sahin Y. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism. Fertil Steril 1998;69(1):66-9
38. Yucelten D, Erenus M, Gurbuz O, et al. Recurrence rate of hirsutism after 3 different antiandrogen therapies. J Am Acad Dermatol 1999;41(1):64-8
39. Isik AZ, Gokmen O, Zeyneloglu HB, et al. Low dose ketoconazole is an effective and relatively safe alternative in the treatment of hirsutism. Aust N Z J Obstet Gynaecol 1996;36(4):487-9
40. Lissak A, Sorokin Y, Calderon I, et al. Treatment of hirsutism with cimetidine: a prospective randomized controlled trial. Fertil Steril 1989;51(2):247-50